Article
Functionalized Fullerene Targeting Human Voltage-Gated Sodium Channel, hNav1.7.
ACS chemical neuroscience - 16 Aug 2017
Hilder Tamsyn A, Robinson Anna, Chung Shin-Ho
Abstract excerpt
Mutations of hNav1.7 that cause its activities to be enhanced contribute to severe neuropathic pain. Only a small number of hNav1.7 specific inhibitors have been identified, most of which interact with the voltage-sensing domain of the voltage-activated sodium ion channel. In our previous computational study, we demonstrated that a [Lys6]-C84 fullerene binds tightly (affinity of 46 nM) to NavAb, the voltage-gated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
